TrademarkDir
STEQUONA
DEAD

Serial Number

79316972

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 11, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

STEQUONA Trademark

Serial Number: 79316972 • Registration: 7014514

STEQUONA is a trademark filed by NOVARTIS AG on June 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 11, 2021

Registration Date

April 4, 2023

Published for Opposition

January 17, 2023

Cancellation Date

October 22, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 22, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 22, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 20, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 4, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 4, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 4, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 31, 2023 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 11, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 11, 2023 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2022 CNSA
AMENDMENT FROM APPLICANT ENTERED
Dec 15, 2022 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 5, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 31, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
May 31, 2022 GNSL
SUSPENSION LETTER WRITTEN
May 31, 2022 CNSL
ASSIGNED TO EXAMINER
Apr 28, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 22, 2022 TROA
REFUSAL PROCESSED BY IB
Nov 15, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Oct 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 28, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 15, 2021 COAR
APPLICATION FILING RECEIPT MAILED
Aug 17, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 7, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Aug 1, 2021 SDRC

Related Trademarks

More from this Owner

JOLBETZY

JOLBETZY

VAYBETRY

VAYBETRY

BEXJUXI

BEXJUXI

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VISANSTA